Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates
Authors:
- 14 October 2015
- journal article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 69 (3) , 173-175
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosisPLOS ONE, 2012
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through EffluxAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug DiscoveryAntimicrobial Agents and Chemotherapy, 2010
- Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis InfectionsJournal of Clinical Microbiology, 2010
- Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous DrugsMicrobial Drug Resistance, 2010
- Genetic diversity of theMycobacterium tuberculosisBeijing family in East Asia revealed through refined population structure analysisFEMS Microbiology Letters, 2009
- Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2008
- Role of mycobacterial efflux transporters in drug resistance: an unresolved questionFEMS Microbiology Reviews, 2006
- mmpL7 Gene of Mycobacterium tuberculosis Is Responsible for Isoniazid Efflux in Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 2005
- Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2002